CTSO · Cytosorbents Corp
Market Cap
$21.61M
Shares
62.84M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.34
Open$0.34
Day$0.31–0.34
52W close$0.31–1.00
Avg vol 30d87K
Short int2.2M · 3.4% float · 29.9d
Short vol49%
Last earningsAug 6, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 23, 2026
Est · unconfirmed
· in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.70
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−40%
below
Price vs 50-day avg
−9%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
4%
near low
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−56%
trailing
YTD return
−47%
this year
Relative strength
−70%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +8 funds added
Insider flow
Accumulating
Net +$148.9K over 90 days · 0% sells
Short interest
Rising
3.43% of float · ▲ +0.7% MoM · 29.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
52 holders — mid 3-yr range
Squeeze score
55
elevated · 0–100
Fundamentals
Revenue growth
+49%
Y/Y
Gross margin
118%
contracting
EPS growth
+66%
Y/Y
Free cash flow
$-12.5M
Balance sheet
$10.4M
net debt
Quant / Vol
risk profile
Volatility
78%
annualized · 1-yr
Max drawdown
−69%
past year
ATR
11.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−40%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
4%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +8 funds added
Insider flow
Accumulating
Net +$148.9K over 90 days · 0% sells
Short interest
Rising
3.43% of float · ▲ +0.7% MoM · 29.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
52 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 4%
Range high $1
vs 200-day avg -40%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CTSO
this stock
Cytosorbents Corp
|
$21.61M | -46.6% | +48.5% | — | 3.4% |
|
ABT
Abbott Laboratories
|
$191.81B | -11.9% | +5.7% | 30.9 | 1.2% |
|
SYK
Stryker Corp
|
$126.84B | -7.9% | +11.2% | 34.3 | 1.8% |
|
MDT
Medtronic plc
|
$116.78B | -5.6% | +8.4% | 24.5 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.00B | -49.3% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CTSO | -7.8% | -7.3% | -56.4% | -5.5% | -46.6% |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -8.3% | -8.6% | -69.7% | -8.2% | -59.1% |
Key facts
CIK
1175151
CUSIP
23283X206
13F (30d)
43 filings
43 filers
Visit website
Investor relations